Stifel Financial’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Stifel Financial’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,260	Closed	-$110K	–	3579
2025 Q2	$110K	Sell	3,260 -563	-15%	-$17.8K	﹤0.01%	3354
2025 Q1	$122K	Buy	3,823 +150	+4%	+$5.69K	﹤0.01%	3270
2024 Q4	$143K	Buy	3,673 +1,028	+39%	+$43.2K	﹤0.01%	3215
2024 Q3	$119K	Sell	2,645 -405	-13%	-$18.1K	﹤0.01%	3219
2024 Q2	$127K	Hold	3,050	–	–	﹤0.01%	3178
2024 Q1	$139K	Buy	+3,050	New	+$139K	﹤0.01%	3146
2023 Q4	–	Sell	-4,138	Closed	-$168K	–	3367
2023 Q3	$168K	Sell	4,138 -456	-10%	-$20.8K	﹤0.01%	3031
2023 Q2	$223K	Sell	4,594 -1,666	-27%	-$83.3K	﹤0.01%	2986
2023 Q1	$308K	Buy	6,260 +276	+5%	+$14.2K	﹤0.01%	2795
2022 Q4	$303K	Buy	+5,984	New	+$309K	﹤0.01%	2763
2022 Q2	–	Sell	-7,140	Closed	-$429K	–	3381
2022 Q1	$429K	Buy	+7,140	New	+$450K	﹤0.01%	2659

Other funds holding GNOM

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Insight Advisors Newtown, Pennsylvania $525M AUM 15.94% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

Stifel Financial's GNOM Position: Q3 2025 in Review

Stifel Financial sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2025, closing a stake of 3,260 shares — an estimated $110K sold.

Stifel Financial first reported a position in GNOM in Q1 2022 and held it in 11 quarters. The position peaked at $429K in Q1 2022. 41 funds tracked by Wall St. Rank hold GNOM as of Q3 2025.

Stifel Financial reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
Stifel Financial sold 3,260 Global X Genomics & Biotechnology ETF shares in Q3 2025, an estimated $110K.
Stifel Financial first reported a position in Global X Genomics & Biotechnology ETF in Q1 2022 and held it in 11 quarters.
Stifel Financial's Global X Genomics & Biotechnology ETF position peaked at $429K in Q1 2022.
41 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2025.

Based on Stifel Financial's 13F filing for Q3 2025, filed 12 Nov 2025.